Chetna Sharon

698 total citations
16 papers, 382 citations indexed

About

Chetna Sharon is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Chetna Sharon has authored 16 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Chetna Sharon's work include Proteoglycans and glycosaminoglycans research (5 papers), Glycosylation and Glycoproteins Research (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Chetna Sharon is often cited by papers focused on Proteoglycans and glycosaminoglycans research (5 papers), Glycosylation and Glycoproteins Research (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Chetna Sharon collaborates with scholars based in United States and Canada. Chetna Sharon's co-authors include Bhaumik B. Patel, Michal Sharon, James M. Rini, Malathy Satkunarajah, Umesh R. Desai, Somesh Baranwal, Dongxia Zhou, Kevin Chen, Marc Desforges and Alan H. M. Wong and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Gastroenterology.

In The Last Decade

Chetna Sharon

16 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chetna Sharon United States	11	165	164	68	64	41	16	382
Yuya Ouchi Japan	13	208 1.3×	75 0.5×	48 0.7×	21 0.3×	12 0.3×	26	421
Abhishek Asthana United States	12	197 1.2×	35 0.2×	9 0.1×	19 0.3×	67 1.6×	20	336
Nanyan Yang China	8	142 0.9×	66 0.4×	9 0.1×	21 0.3×	53 1.3×	12	310
Tiziana Cervelli Italy	13	383 2.3×	24 0.1×	15 0.2×	12 0.2×	112 2.7×	33	577
Ying Fang China	9	278 1.7×	19 0.1×	9 0.1×	12 0.2×	92 2.2×	17	448
Janice Murtagh United States	8	199 1.2×	17 0.1×	7 0.1×	44 0.7×	79 1.9×	11	312
Yan G. Fulcher United States	11	157 1.0×	61 0.4×	8 0.1×	25 0.4×	81 2.0×	14	344
Stephanie Oerum France	11	703 4.3×	36 0.2×	12 0.2×	15 0.2×	59 1.4×	14	766
Penghui Jia China	10	165 1.0×	32 0.2×	4 0.1×	17 0.3×	66 1.6×	21	342
Xiaoyuan Jia China	11	213 1.3×	15 0.1×	16 0.2×	13 0.2×	108 2.6×	31	391

Countries citing papers authored by Chetna Sharon

Since Specialization

Citations

This map shows the geographic impact of Chetna Sharon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chetna Sharon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chetna Sharon more than expected).

Fields of papers citing papers by Chetna Sharon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chetna Sharon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chetna Sharon. The network helps show where Chetna Sharon may publish in the future.

Co-authorship network of co-authors of Chetna Sharon

This figure shows the co-authorship network connecting the top 25 collaborators of Chetna Sharon. A scholar is included among the top collaborators of Chetna Sharon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chetna Sharon. Chetna Sharon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Morla, Shravan, Alberto Vera, Daniel K. Afosah, et al.. (2023). Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity. Journal of Medicinal Chemistry. 66(2). 1321–1338. 7 indexed citations

Shah, Tilak, et al.. (2023). PHASE 1 DOSE-FREQUENCY ESCALATION STUDY OF NEOADJUVANT CRYOTHERAPY IN LOCALLY ADVANCED ESOPHAGEAL CANCER. Gastrointestinal Endoscopy. 97(6). AB1106–AB1107. 1 indexed citations

Sankaranarayanan, Nehru Viji, Balaji Nagarajan, Chetna Sharon, et al.. (2022). Glycan Modulation of Insulin‐like Growth Factor‐1 Receptor. Angewandte Chemie. 134(49). 1 indexed citations

Sankaranarayanan, Nehru Viji, Balaji Nagarajan, Chetna Sharon, et al.. (2022). Glycan Modulation of Insulin‐like Growth Factor‐1 Receptor. Angewandte Chemie International Edition. 61(49). e202211320–e202211320. 11 indexed citations

Wu, Y. Jeffrey, Chetna Sharon, Howard Li, et al.. (2021). High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity. Neoplasia. 23(3). 348–359. 13 indexed citations

Sharon, Chetna, Shravan Morla, Donald F. Brophy, et al.. (2018). A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. Molecular Cancer Therapeutics. 18(1). 51–61. 31 indexed citations

Morla, Shravan, Alhumaidi B. Alabbas, Ravi Kalathur, et al.. (2018). Polymeric fluorescent heparin as one-step FRET substrate of human heparanase. Carbohydrate Polymers. 205. 385–391. 18 indexed citations

Damle, Priyadarshan K., et al.. (2018). Abstract 3460: p38-p14ARF-CtBP2 axis as a novel regulator of CSC phenotype and tumor cell dormancy. Cancer Research. 78(13_Supplement). 3460–3460. 1 indexed citations

Sharon, Chetna, et al.. (2018). Sa1196 - Steroidogenic Acute Regulatory Protein (Start) Related Lipid Transfer Domain Containing 5 (Stard5) is a Novel Target for Colon Cancer Stem Cells. Gastroenterology. 154(6). S–274. 2 indexed citations

10.

Sharon, Chetna & Michal Sharon. (2017). Studies on Biodegradation of Polyethylene terephthalate: A synthetic polymer. 2(2). 248–257. 35 indexed citations

11.

Wong, Alan H. M., Aidan C.A. Tomlinson, Dongxia Zhou, et al.. (2017). Receptor-binding loops in alphacoronavirus adaptation and evolution. Nature Communications. 8(1). 1735–1735. 70 indexed citations

12.

Sharon, Chetna, et al.. (2016). Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase. Oncotarget. 7(51). 84608–84622. 34 indexed citations

13.

Sharon, Chetna, Somesh Baranwal, Daniel Rodrı́guez-Agudo, et al.. (2015). Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathwayin vitroandin vivo. Oncotarget. 6(17). 15332–15347. 27 indexed citations

14.

Pak, John E., Chetna Sharon, Malathy Satkunarajah, et al.. (2009). Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain. Journal of Molecular Biology. 388(4). 815–823. 41 indexed citations

15.

Zakhartchouk, Alexander N., Chetna Sharon, Malathy Satkunarajah, et al.. (2006). Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: Implications for a subunit vaccine. Vaccine. 25(1). 136–143. 62 indexed citations

16.

Park, Ki Ho, et al.. (2003). N ‐glycosylation‐dependent block is a novel mechanism for drug‐induced cardiac arrhythmia. The FASEB Journal. 17(15). 2308–2309. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact